Aspire Private Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Buy |
1,017
+369
| +57% | +$143K | 0.09% | 142 |
|
|
2025
Q1 | $282K | Buy |
+648
| New | +$282K | 0.07% | 157 |
|
|
2024
Q4 | – | Sell |
-37
| Closed | -$19.2K | – | 300 |
|
|
2024
Q3 | $19.2K | Hold |
37
| – | – | ﹤0.01% | 309 |
|
|
2024
Q2 | $20K | Sell |
37
-10
| -21% | -$5.4K | 0.01% | 315 |
|
|
2024
Q1 | $24.3K | Sell |
47
-11
| -19% | -$5.68K | 0.01% | 300 |
|
|
2023
Q4 | $27.7K | Sell |
58
-1,292
| -96% | -$616K | 0.01% | 274 |
|
|
2023
Q3 | $588K | Buy |
1,350
+70
| +5% | +$30.5K | 0.19% | 79 |
|
|
2023
Q2 | $569K | Buy |
1,280
+52
| +4% | +$23.1K | 0.18% | 90 |
|
|
2023
Q1 | $565K | Buy |
1,228
+1,216
| +10,133% | +$559K | 0.19% | 89 |
|
|
2022
Q4 | $6.22K | Hold |
12
| – | – | ﹤0.01% | 410 |
|
|
2022
Q3 | $5K | Hold |
12
| – | – | ﹤0.01% | 414 |
|
|
2022
Q2 | $6K | Hold |
12
| – | – | ﹤0.01% | 380 |
|
|
2022
Q1 | $6K | Sell |
12
-8
| -40% | -$4K | ﹤0.01% | 375 |
|
|
2021
Q4 | $9K | Buy |
20
+8
| +67% | +$3.6K | ﹤0.01% | 348 |
|
|
2021
Q3 | $4K | Hold |
12
| – | – | ﹤0.01% | 406 |
|
|
2021
Q2 | $5K | Hold |
12
| – | – | ﹤0.01% | 385 |
|
|
2021
Q1 | $4K | Buy |
12
+6
| +100% | +$2K | ﹤0.01% | 405 |
|
|
2020
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 375 |
|
|
2020
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 372 |
|
|
2020
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 267 |
|
|
2020
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 205 |
|
|
2019
Q4 | $2K | Sell |
6
-9
| -60% | -$3K | ﹤0.01% | 374 |
|
|
2019
Q3 | $4K | Hold |
15
| – | – | ﹤0.01% | 294 |
|
|
2019
Q2 | $4K | Buy |
15
+8
| +114% | +$2.13K | ﹤0.01% | 327 |
|
|
2019
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 427 |
|
|
2018
Q4 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 409 |
|